[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334611-105":59,"doc-detail-334611-en":123},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":116,"head_meta":118,"extra_data":120,"updated_unix":122},105,"en","long-term-oncological-outcomes-of-transanal-versus-laparoscopic-total-mesorectal-excision-for-mid-low-rectal-cancer-retrospective-analysis-of-2502-patients","Long-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer - retrospective analysis of 2502 patients","","Retrospective cohort evidence compares transanal total mesorectal resection (taTME) with laparoscopic total mesorectal excision (laTME) for mid-low rectal cancer, targeting long-term survival and recurrence endpoints. Patients were identified from two prospective cohorts between July 2014 and June 2022, with propensity score matching to balance baseline characteristics. In 2502 included patients, 5-year overall and disease-free survival were similar pre- and post-matching. Subgroup findings in low rectal cancer suggested potential reductions in death and cancer recurrence risk, supporting comparable oncologic safety and possible survival benefits.",{"@graph":69,"@context":115},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/long-term-oncological-outcomes-of-transanal-versus-laparoscopic-total-mesorectal-excision-for-mid-low-rectal-cancer-retrospective-analysis-of-2502-patients/334611/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/long-term-oncological-outcomes-of-transanal-versus-laparoscopic-total-mesorectal-excision-for-mid-low-rectal-cancer-retrospective-analysis-of-2502-patients/334611.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109],{"name":110,"@type":111,"acceptedAnswer":112},"Did the study find benefits in any subgroup?","Question",{"text":113,"@type":114},"Subgroup analysis suggested that taTME may reduce the risk of death and disease recurrence in patients with low rectal cancer, based on reported hazard ratios and confidence intervals.","Answer","https://schema.org",{"og:url":83,"og:type":117,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":119,"canonical":83},"index,follow",{"doc_id":121,"site_id":62},334611,1790095159,{"code":4,"msg":5,"data":124},{"doc_id":121,"user_id":125,"nickname":92,"user_avatar":126,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","’Retrospective Cohort Study  \nLong-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer: a retrospective analysis of 2502 patients  \nZe Li, MDa,b,c , Huashan Liu, MD, PhDa,b,c , Shuangling Luo, MD, PhDa,b,c , Yujie Hou, MDa,b,c , Yebohao Zhou, MDa,b,c , Xiaobin Zheng, MDa,b,c , Xingwei Zhang, MDa,b,c , Liang Huang, MD, PhDa,b,c,* , Ziwei Zeng, MDa,b,c,d,* ,  \nLiang Kang, MD, PhDa,b,c,*  \nBackground: Transanal total mesorectal resection (taTME) has recently emerged as a promising surgical approach for the  treatment of mid-low rectal cancer. However, there is limited evidence on the long-term survival outcomes associated with taTME. This retrospective study aimed to compare the overall survival (OS), disease-free survival (DFS), and cancer-speciﬁc survival of taTMEand laparoscopic TME (laTME) in patients with mid-low rectal cancer.  \nMaterials and Methods: From July 2014 to June 2022, a total of 3627 patients were identiﬁed from two prospective cohorts: the laparoscopic rectal surgery cohort and the CNTAES cohort. To balance the baseline characteristics between the taTME and laTME groups, propensity score matching (PSM) was performed.  \nResults: A total of 2502 patients were included in the study. Prior to PSM, the laTME group comprised 1853 patients, while the taTME group comprised 649 patients. The 5-year OS (82 .9% vs. 80.4%, P = 0.202) and 5-year DFS (74 .4% vs. 72.5%, P = 0. 167) were comparable between the taTME and laTME groups. After PSM, the taTME group showed no statistically signiﬁcant difference in the 5-year OS (83 . 1% vs. 79.2%, P = 0. 101) and 5-year DFS (74 .8% vs. 72. 1%, P = 0. 135) compared to the laTME group. Subgroup analysis further suggested that taTME may potentially reduce the risk of death [hazard ratio 0.652; (95% CI, 0.452–0.939)] and disease recurrence [hazard ratio 0 .736; (95% CI, 0 .562–0.965)] speciﬁcally in patients with low rectal cancer.  \nConclusion: In this study, taTME demonstrated comparable oncologic safety to laTME in patients with mid-low rectal cancer. Moreover, the results indicate that taTME may confer potential survival beneﬁts for patients with low rectal cancer.  \nKeywords: laparoscopic surgery, local recurrence, rectal cancer, total mesorectal excision, transanal total mesorectal excision  \nIntroduction  \nThe management of rectal cancer inherently involves a multidisciplinary approach, with surgery playing a crucial role in the treatment process. Total mesorectal excision (TME) is the standard surgical procedure for mid-low rectal cancer[1] . With the rise of minimally invasive surgery, laparoscopic TME (laTME) has  \nbecome increasingly popular[2] . Several randomized controlled trials (RCTs) have shown that laTME is comparable to open TME (opTME) in terms of oncological outcomes for mid-low rectal cancer[3–5] . In addition to achieving similar oncological outcomes, laTME has the advantage of enhancing recovery and reducing postoperative complications[6] . However, obese male  \naDepartment of General Surgery (Colorectal Surgery), bGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, cBiomedical Innovation Center, The Sixth Afﬁliated Hospital, Sun Yat-sen University, Guangzhou, China and dUniversity Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Z.L., H.L. and S.L. contributed equally.  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding Author. Address: Department of Colorectal Surgery, Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Afﬁliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510655, P. R. China. University Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Tel.:/fax: +86 20 384 553 69. E-mail: [lzengzw@mail2.sysu.edu.cn](lzengzw@mail2.sysu.edu.cn) (Z","cbCaiusmkrKmeoVg","https://ap.wps.com/l/cbCaiusmkrKmeoVg","pdf",592239,"English","# Background\n## Study aim\n# Materials and Methods\n## Patient cohorts and timeframe\n## Propensity score matching\n# Results\n## Included patient numbers\n## 5-year survival outcomes\n## Subgroup hazard ratios\n# Conclusion\n## Oncologic safety and potential benefits","[{\"question\":\"Did the study find benefits in any subgroup?\",\"answer\":\"Subgroup analysis suggested that taTME may reduce the risk of death and disease recurrence in patients with low rectal cancer, based on reported hazard ratios and confidence intervals.\"}]","Long-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer - retrospective analysis of 2502 patients | PDF",1790007460,23]